Fresenius Renal Pharmaceuticals specializes in the prescription needs of the ESRD patient and is dedicated to providing pharmaceuticals to the more than 400,000 individuals undergoing dialysis throughout the United States.
Our renal pharmaceutical products include Velphoro® (sucroferric oxyhydroxide) chewable tablets, Venofer® (iron sucrose injection USP) and PhosLyra® (calcium acetate oral solution).

website: https://www.velphorohcp.com/